Clinical Trial Update: A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 non-inferiority trial compares two filgrastim preparations for preventing neutropenia in breast cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Filgrastim (preparation A) (filgrastim)
• Filgrastim (preparation B) (filgrastim)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Neutropenia in Breast Cancer | Phase 3 | Status: COMPLETED